Breaking
KRBusan Haeundae-gu, BEXCO job fair tomorrowDEHistoric defeat: ANC collapses in local elections in South AfricaDEChip giant: Nvidia boss had an affair with a possible spyBR1st day of Enem: check out the unofficial answer sheet and answer videoKRSamsung and Google AI glasses available for pre-order on the 12th... Challenge the meta soloKRSeoul stocks move up late Monday morning on chip reboundCNTwo consecutive shootings occurred on the University of North Carolina campus! 1 dead and 3 injured, 1 suspect arrestedTRExplosion and fire on electricity pole in ŞişliKRCollision between 2 trains in Egypt kills 7 and injures at least 125KRPoland calls Krakow shooting rampage 'terrorist' attackKRBusan Haeundae-gu, BEXCO job fair tomorrowDEHistoric defeat: ANC collapses in local elections in South AfricaDEChip giant: Nvidia boss had an affair with a possible spyBR1st day of Enem: check out the unofficial answer sheet and answer videoKRSamsung and Google AI glasses available for pre-order on the 12th... Challenge the meta soloKRSeoul stocks move up late Monday morning on chip reboundCNTwo consecutive shootings occurred on the University of North Carolina campus! 1 dead and 3 injured, 1 suspect arrestedTRExplosion and fire on electricity pole in ŞişliKRCollision between 2 trains in Egypt kills 7 and injures at least 125KRPoland calls Krakow shooting rampage 'terrorist' attack
Newsgather
All StoriesWorldSportsFinanceTechScienceHealthCultureClimatePoliticsSpace
BackThe Diabetes Health Education Association, Japan, South Korea and other countries jointly developed/Asia’s first weight-loss injection guidelines to be released as soon as January next year
The Diabetes Health Education Association, Japan, South Korea and other countries jointly developed/Asia’s first weight-loss injection guidelines to be released as soon as January next year
Developing
自由时报5 hours agoHealth2 min readChinaView original

The Diabetes Health Education Association, Japan, South Korea and other countries jointly developed/Asia’s first weight-loss injection guidelines to be released as soon as January next year

It is expected to be published in an international academic journal in January next year, covering side effects prevention, response and reminders.

thin needleenterocrineGLP-1

Quick Look

  • The Diabetes Health Education Society plans to invite domestic societies to jointly publish Asia's first special guidelines on the side effects of slimming injections with Japan, South Korea and other Asian countries.
  • The first draft is expected to be drafted by the end of November and published in international academic journals in January next year.
  • The content covers situations such as drug withdrawal before surgery, dose conversion and overdose management.

AI-generated summary

Why It Matters

In recent years, incretin drugs, commonly known as "slimming shots", are not only used as diabetes treatment drugs, but are also regarded by many people as a weight loss tool. Its side effects have attracted attention from all walks of life.

Font size

In recent years, the side effects of slimming injections have attracted attention from all walks of life. Schematic diagram. (Picture taken from shutterstock)

In recent years, the enterocrine drug, commonly known as the "slimming shot", has been released. In addition to being used as a treatment for diabetes, it is also regarded by many people as a weight loss tool. The Diabetes Health Education Society plans to invite other domestic societies to participate in the discussion, and jointly publish Asia's first special guidelines covering the prevention, response and reminders of side effects related to slimming injections with Japan, South Korea and other Asian countries, and hopes to publish them in international academic journals in January next year.

Ou Hongyi, chairman of the Diabetes Health Education Association, pointed out that there are many situations that require special attention after using the "Slimming Injection". For example, before surgery or anesthesia, if there is food in the stomach, it may cause choking and cause danger. GLP-1 drugs will slow down the gastric emptying speed after use, allowing food to stay in the stomach for a long time. Therefore, users need to stop taking the medicine two weeks in advance before surgery or anesthesia.

Ou Hongyi mentioned that the association has noticed the importance of medication safety and avoiding side effects for slimming needle users, and plans to invite representatives from different domestic societies to participate in discussions and jointly develop formal guidelines with Japan, South Korea and other Asian countries. The content will include the use of slimming needles for various purposes such as weight loss and diabetes control, as well as countermeasures that should be taken to reduce side effects, such as whether medication needs to be discontinued in various situations such as surgery and hospitalization.

In addition, Ou Hongyi said that the guidelines also plan to include precautions when switching between different types of slimming injections, how to deal with excessive doses by mistake, and other all-encompassing scenarios. The society is still taking stock of the content that should be included in the guidelines. It is expected to formulate a first draft by the end of November and hopes to officially publish it through international academic journals in January next year. It is expected to become Asia's first precautions for the side effects of slimming injections.

Regarding the public's increasing attention to the side effects of slimming injections in recent years, Ou Hongyi emphasized that the benefits of incretin and related drugs do exist, and the side effects also need to be paid attention to and avoided through appropriate practices. The future guidance is not intended to cause panic among the public, but to allow the drugs to play their maximum role under safe conditions.

What to Watch

AI outlook — possibilities, not facts

  • The guidelines will be officially released through international academic journals in January next year, becoming Asia's first guidelines on the side effects of slimming injections.

    Likely · Within months

Open Questions

  • Which domestic academic societies and Asian countries will be included in the guidelines?
  • Actual implementation and promotion methods after the publication of the guidelines
  • Specific precautions when switching between different types of slimming needles

Related Topics

thin needle
PeopleOu Hongyi
OrganizationsDiabetes Health Education Association
TopicsenterocrineGLP-1Diabetes Health Education Associationside effectsOu HongyiAsia Guide
This article was originally published by 自由时报.

Related Stories

Urinary incontinence is not the fate of aging! 60-year-old woman regains laughter with 20-minute minimally invasive surgery
Health·

Urinary incontinence is not the fate of aging! 60-year-old woman regains laughter with 20-minute minimally invasive surgery

Cai Zhengyan, a urologist at China Medical University Hsinchu Hospital, explained that injecting biocompatible hydrogel filling material into the urethral wall through an endoscope can increase the closing force of the urethra. The treatment only takes about 20 minutes, and the patient is discharged the next day. It is suitable for patients with stress urinary incontinence.

自由时报
3 min read
The refusal of elderly people with dementia to eat may not be due to a simple lack of appetite. Improvements in hand-held meals, pay attention to the risk of depression and suicide
Health·

The refusal of elderly people with dementia to eat may not be due to a simple lack of appetite. Improvements in hand-held meals, pay attention to the risk of depression and suicide

In response to the problem of elderly people with dementia who refuse to eat, Xinying Hospital promotes "hand-held meals" to design meals into small portions that are easy to take and preserve the dignity of the elderly's independent eating. Doctors pointed out that food refusal may be related to forgetting eating steps, difficulty in operating tableware, depression and suicide risk, and requires integrated care from neurology, psychiatry, nursing, nutrition and swallowing rehabilitation teams.

自由时报
2 min read
Care Online》Don’t give up on advanced liver cancer! "Double immunotherapy" paid by health insurance can help "reverse" the course of the disease, a lazy guide with pictures and texts by specialists
Health·

Care Online》Don’t give up on advanced liver cancer! "Double immunotherapy" paid by health insurance can help "reverse" the course of the disease, a lazy guide with pictures and texts by specialists

Chen Baiyue, a gastrointestinal and hepatobiliary physician at Chiayi Christian Hospital, pointed out that dual immunotherapy has been included in health insurance benefits as one of the treatment options for advanced liver cancer. By combining two immune checkpoint inhibitors to activate the autoimmune system, about 20% of patients can have their tumors significantly shrunk or even reversed to the stage of surgical resection, and are less likely to suffer side effects of liver damage.

自由时报
3 min read
There were 63 cases of adverse reactions of Slimming Injections reported this year / 39 cases were reported for weight loss purposes, more than 60%. Most of the symptoms were gastrointestinal diseases.
Health·

There were 63 cases of adverse reactions of Slimming Injections reported this year / 39 cases were reported for weight loss purposes, more than 60%. Most of the symptoms were gastrointestinal diseases.

According to statistics from the Food and Drug Administration, this year it received 63 reports of suspected adverse reactions to GLP-1 receptor agonist drugs, of which 39 were for weight loss and 24 were for diabetes treatment. Most of the symptoms were gastrointestinal diseases. The Food and Drug Administration has required pharmaceutical manufacturers to develop post-marketing safety research plans and risk assessment and control plans, and reminds the public that such injections are prescribed by doctors and should not be purchased and administered on their own.

自由时报
3 min read
《TAIPEI TIMES》 Guide on weight-loss drugs planned
Health·

《TAIPEI TIMES》 Guide on weight-loss drugs planned

The Taiwan Diabetes Education Association plans to work with domestic and regional partners to develop Asia's first GLP-1 drug side effect prevention and management guidelines, covering safe use in weight loss and diabetes management, which are expected to be published in international academic journals in January next year. Taiwan's Food and Drug Administration has received 63 reports of suspected adverse reactions involving GLP-1 receptor agonists this year, mainly gastrointestinal problems.

自由时报
2 min read
Two years after stopping the medication, my blood pressure is still normal! The new drug baxdrostat, which inhibits aldosterone, may be a new dawn for "surgery-free" treatment for certain patients with hypertension.
Developing·

Two years after stopping the medication, my blood pressure is still normal! The new drug baxdrostat, which inhibits aldosterone, may be a new dawn for "surgery-free" treatment for certain patients with hypertension.

A study led by Queen Mary, University of London found that after the new drug baxdrostat was used to treat patients with primary aldosteronism, some patients' blood pressure returned to normal after stopping the drug for up to two years, which is expected to "cure" hypertension. The findings were published in the New England Journal of Medicine and NICE is assessing whether the drug should be made available on the NHS.

自由时报
3 min read
More on this topicthin needle